Escalon Medical (ESMC) Receives FDA 510(K) Clearance for D3 Hematology System
More News related to ESMC
- Escalon Medical (ESMC) Sells 1.15M Shares in Private Placement
- Escalon(R) (ESMC) Receives FDA 510(k) Clearance to Market the LIASYS(TM) Clinical Chemistry and Immunoturbidimetric Analyzer
- Escalon Medical (ESMC) Receives FDA 510(K) Clearance For VascuView(TM)
- Escalon Medical (ESMC) Subsidiary Receives FDA 510(k) Clearance
- Escalon Medical (ESMC) Receives FDA 510(K) Clearance for D3 Hematology System
More News related to FDA
- AspenBio Pharma (APPY) Reports Results from Interim Analysis for Ongoing Trial of AppyScore
- XenoPort (XNPT) Said FDA Moves PDUFA Date Due to February 11
- Dendreon (DNDN) CEO Says Provenge Salesforce Will Be 125 People, Sees Full Manufacturing Ability by Mid-2011
- U.S. FDA to Become More Stringent on Medical Imaging Equipment (GE, SI)
- BSD Medical (BSDM) Initiates Phase 3 Clinical Study of BSD-2000 Hyperthermia System
Escalon Medical Corp. (Nasdaq: ESMC) said Drew Scientific subsidiary received 510(k) clearance from the FDA to market the D3 Hematology System, an automatic three-part differential Hematology Analyzer.
Related Categories
FDAStocks Mentioned
+0.00Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
